Alistair McGuire
About
In The Last Decade
Alistair McGuire
179 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 186
- Economics and Econometrics 2.8k
- General Health Professions 1.9k
- Surgery 1.6k
- Cardiology and Cardiovascular Medicine 1.3k
- Epidemiology 764
Countries citing papers authored by Alistair McGuire
This map shows the geographic impact of Alistair McGuire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alistair McGuire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alistair McGuire more than expected).
Fields of papers citing papers by Alistair McGuire
This network shows the impact of papers produced by Alistair McGuire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alistair McGuire. The network helps show where Alistair McGuire may publish in the future.
Co-authorship network of co-authors of Alistair McGuire
This figure shows the co-authorship network connecting the top 25 collaborators of Alistair McGuire. A scholar is included among the top collaborators of Alistair McGuire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alistair McGuire. Alistair McGuire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 8 | |
| 4 | Coordinating hospital discharges: bed blocking in England | 1 |
| 5 | 6 | |
| 6 | Technology Diffusion in Health Care: Conceptual Aspects and Evidence | 1 |
| 7 | 24 | |
| 8 | Explaining Early Adoption on New Medicines: Regulation, Innovation and Scale | 4 |
| 9 | Do international launch strategies of pharmaceutical corporations respond to changes in the regulatory environment | 2 |
| 10 | Persistence despite action? Measuring the patterns of health inequality in England (1997-2007) | 1 |
| 11 | Optimising operating list scheduling in the day surgery department: can statistical modelling help? | 1 |
| 12 | Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK (Heart (2004) 90, (286-292)) | 26 |
| 13 | Inferring the value of medical research to the UK | 2 |
| 14 | 11 | |
| 15 | The cost of care: is there an optimal level of expenditure? | 3 |
| 16 | 280 | |
| 17 | The cost-effectiveness of preventing initial coronary events with pravastatin | 3 |
| 18 | The economics of health care: an introductory text | 102 |
| 19 | Medical ethics and economics in health care | 11 |
| 20 | Global restructuring, local response | 32 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.